Jeffrey G. Black

Jeffrey G. Black is an experienced financial executive currently serving as Chief Financial Officer at Exagen Inc., a life sciences company, since September 2024. Previously, Jeffrey held CFO positions at Standard BioTools, Apollo Endosurgery, Alphatec Spine, Applied Proteomics, AltheaDx, and Verenium, where significant financial milestones were achieved including the strategic sale of Apollo Endosurgery to Boston Scientific for $615M and orchestrating financing transactions amounting to nearly $500M at Alphatec Spine. Earlier career roles included positions at Ionis Pharmaceuticals, Clarent Corporation, and Accelerated Networks, where Jeffrey was instrumental in crisis management. Jeffrey holds a BS in Business with a focus on Accounting and Marketing from the University of Arizona.